CIPLA
|
The Current P/S Ratio of CIPLA is 4.18.
| Share Price | ₹1,467.3 | Jan 07,2026 |
| Market Cap | ₹118,528.5 Cr | |
| Sales-TTM | ₹28,349.6 Cr | TTM-Consolidated Results |
| Price/Sales | 4.18x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of CIPLA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹118,528.5 Cr] as on Jan 07,2026
(/) Sales [ ₹28,349.6 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 4.18x ]
Thus, for CIPLA , the investors are currently willing to pay '4.18 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of CIPLA !
The chart below summarizes the trend in P/S Ratio of CIPLA over the last five years.
Historical PS (Price/Sales) ratio chart of CIPLA
PS Ratio Performance Analysis for CIPLA
- CIPLA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.86x.
- CIPLA 's operated at median p/e ratio of 3.78x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, CIPLA 's p/e ratio peaked in Mar2024 at 4.68x.
- CIPLA 's p/e ratio hit its five-year low in Mar2023 of 3.19x.
How does CIPLA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| CIPLA | 28,349.6 | 4.18 | 118,528.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.78 | 427,681.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 17.58 | 176,324.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 11.31 | 138,466.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 3.02 | 103,711.0 |
| MANKIND PHARMA LTD | 13,576.9 | 7.03 | 95,424.0 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.81 | 93,298.0 |
| LUPIN LTD | 24,750.7 | 4.09 | 101,115.0 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.21 | 71,746.4 |
| ABBOTT INDIA LTD | 6,714.4 | 9.02 | 60,547.2 |
| ALKEM LABORATORIES LTD | 13,890.2 | 4.98 | 69,231.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs CIPLA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.21x |
| Max industry PS | 17.58x |
| Median industry PS | 4.98x |
| Average industry PS | 6.82x |
You may also like the below Video Courses